XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Premiums $ 290,827 $ 257,157 $ 226,233
Investment and other income 4,089 2,030 2,324
Total revenues 371,622 324,162 287,597 CloseClose
Operating costs:      
Medical costs 241,894 210,842 186,911
Operating costs 54,628 47,782 42,579
Cost of products sold 38,770 33,703 31,034
Depreciation and amortization 3,972 3,400 3,103
Total operating costs 339,264 295,727 263,627 Close
Earnings from operations 32,358 28,435 23,970 Close
Interest expense (3,246) (2,092) (1,660) CloseClose
Total Other Income Expenses -3246.0 -2092.0 -1660.0 0.0 0 Close
Earnings before income taxes 29,112 26,343 22,310 CloseCloseClose
Provision for income taxes (5,968) (5,704) (4,578) CloseClose
Net earnings 23,144 20,639 17,732 CloseClose
Earnings attributable to noncontrolling interests (763) (519) (447)
Net earnings attributable to UnitedHealth Group common shareholders $ 22,381 $ 20,120 $ 17,285
Earnings per share attributable to UnitedHealth Group common shareholders:      
Basic $ 24.12 $ 21.47 $ 18.33
Diluted $ 23.86 $ 21.18 $ 18.08
Basic weighted-average number of common shares outstanding 928 937 943
Dilutive effect of common share equivalents 10 13 13
Diluted weighted-average number of common shares outstanding 938 950 956
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 6 3 1
Products      
Revenues:      
Revenue from Products and Services $ 42,583 $ 37,424 $ 34,437
Services      
Revenues:      
Revenue from Products and Services $ 34,123 $ 27,551 $ 24,603